Search research articles
Contact Us
Filters
Showing results (171-180 of 224) with videos related to
Page
of 23
Sort By:
Blood
|
September 3, 2015
Prediction of high- and low-risk multiple myeloma based on gene expression and the International Staging System
Rowan Kuiper, Mark van Duin, Martin H van Vliet, et al.
Blood Cancer Journal
|
November 25, 2018
Clinical predictors of long-term survival in newly diagnosed transplant eligible multiple myeloma - an IMWG Research Project
Saad Z Usmani, Antje Hoering, Michele Cavo, et al.
Blood
|
November 25, 2003
Molecular basis of the spectral expression of CIAS1 mutations associated with phagocytic cell-mediated autoinflammatory disorders CINCA/NOMID, MWS, and FCU
Bénédicte Neven, Isabelle Callebaut, Anne-Marie Prieur, et al.
Nature Communications
|
April 27, 2018
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression
Mina Ali, Ram Ajore, Anna-Karin Wihlborg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 6, 2020
Ixazomib as Postinduction Maintenance for Patients With Newly Diagnosed Multiple Myeloma Not Undergoing Autologous Stem Cell Transplantation: The Phase III TOURMALINE-MM4 Trial
Meletios A Dimopoulos, Ivan Špička, Hang Quach, et al.
Plos One
|
November 16, 2016
Systematic Review and Meta-Analysis of Randomised Trials to Ascertain Fatal Gastrointestinal Bleeding Events Attributable to Preventive Low-Dose Aspirin: No Evidence of Increased Risk
Peter C Elwood, Gareth Morgan, Julieta Galante, et al.
Blood
|
July 26, 2014
The sialyltransferase ST3GAL6 influences homing and survival in multiple myeloma
Siobhan V Glavey, Salomon Manier, Alessandro Natoni, et al.
The Oncologist
|
July 27, 2014
European perspective on multiple myeloma treatment strategies in 2014
Heinz Ludwig, Pieter Sonneveld, Faith Davies, et al.
American Journal of Hematology
|
April 7, 2017
Clinical characteristics and prognostic factors in multiple myeloma patients with light chain deposition disease
Meera Mohan, Amy Buros, Pankaj Mathur, et al.
Cancer Treatment Reviews
|
September 25, 2010
Treatment of relapsed and refractory multiple myeloma in the era of novel agents
Niels W C J van de Donk, Henk M Lokhorst, Meletios Dimopoulos, et al.
Page
of 23
Search research articles
Search
Showing results (171-180 of 224) with videos related to
Sort By:
Page
of 23
Blood
|
September 3, 2015
Prediction of high- and low-risk multiple myeloma based on gene expression and the International Staging System
Rowan Kuiper, Mark van Duin, Martin H van Vliet, et al.
Blood Cancer Journal
|
November 25, 2018
Clinical predictors of long-term survival in newly diagnosed transplant eligible multiple myeloma - an IMWG Research Project
Saad Z Usmani, Antje Hoering, Michele Cavo, et al.
Blood
|
November 25, 2003
Molecular basis of the spectral expression of CIAS1 mutations associated with phagocytic cell-mediated autoinflammatory disorders CINCA/NOMID, MWS, and FCU
Bénédicte Neven, Isabelle Callebaut, Anne-Marie Prieur, et al.
Nature Communications
|
April 27, 2018
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression
Mina Ali, Ram Ajore, Anna-Karin Wihlborg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 6, 2020
Ixazomib as Postinduction Maintenance for Patients With Newly Diagnosed Multiple Myeloma Not Undergoing Autologous Stem Cell Transplantation: The Phase III TOURMALINE-MM4 Trial
Meletios A Dimopoulos, Ivan Špička, Hang Quach, et al.
Plos One
|
November 16, 2016
Systematic Review and Meta-Analysis of Randomised Trials to Ascertain Fatal Gastrointestinal Bleeding Events Attributable to Preventive Low-Dose Aspirin: No Evidence of Increased Risk
Peter C Elwood, Gareth Morgan, Julieta Galante, et al.
Blood
|
July 26, 2014
The sialyltransferase ST3GAL6 influences homing and survival in multiple myeloma
Siobhan V Glavey, Salomon Manier, Alessandro Natoni, et al.
The Oncologist
|
July 27, 2014
European perspective on multiple myeloma treatment strategies in 2014
Heinz Ludwig, Pieter Sonneveld, Faith Davies, et al.
American Journal of Hematology
|
April 7, 2017
Clinical characteristics and prognostic factors in multiple myeloma patients with light chain deposition disease
Meera Mohan, Amy Buros, Pankaj Mathur, et al.
Cancer Treatment Reviews
|
September 25, 2010
Treatment of relapsed and refractory multiple myeloma in the era of novel agents
Niels W C J van de Donk, Henk M Lokhorst, Meletios Dimopoulos, et al.
Page
of 23